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A commentary on
Circulating microRNAs in Alzheimer’s
disease: the search for novel biomarkers
by Dorval, V., Nelson, P. T., and Hébert, S.
S. (2013). Front. Mol. Neurosci. 6:24. doi:
10.3389/fnmol.2013.00024
An error has been pointed out under the
section CSF after our mini-review was
published. At the end of the last para-
graph, the reported correlations have
been wrongly assigned to Alexandrov
et al. The correct citation for this work is
“Geekiyanage, H., and Chan, C. (2011).
MicroRNA-137/181c regulates serine
palmitoyltransferase and in turn amyloid
beta, novel targets in sporadic Alzheimer’s
disease. J. Neurosci. 31, 14820–14830.
doi: 10.1523/JNEUROSCI.3883-11.2011.”
However, these results were obtained
from the study of frontal cortices of
Alzheimer’s patients, not the CSF. Thus,
caution should be taken with regards
to this work, which is unfortunately
no longer in the scope of the present
mini-review on circulating microRNAs as
biomarkers.
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